Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roger Douglas Weiss, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21DA041682 (CHAN, KEVIN E) Mar 15, 2017 - Oct 30, 2018
    NIH
    Opioid Use and Abuse in the Dialysis Population
    Role: Co-Principal Investigator
  2. K24DA022288 (WEISS, ROGER D.) Apr 1, 2007 - Aug 31, 2017
    NIH
    Mentoring in drug abuse and dual diagnosis research
    Role: Principal Investigator
  3. UG1DA015831 (CARROLL, KATHLEEN M.) Sep 30, 2002 - May 31, 2020
    NIH
    The National Drug Abuse Clinical Trials Network: New England Consortium Node
    Role: Co-Principal Investigator
  4. U10DA015831 (WEISS, ROGER D.) Sep 30, 2002 - Aug 31, 2015
    NIH
    The National Drug Abuse Treatment Clinical Trials Network (U10)
    Role: Co-Principal Investigator
  5. R01DA015968 (WEISS, ROGER D.) Sep 30, 2002 - May 31, 2007
    NIH
    Modifying Group Therapy for Bipolar Abusers
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply. J Addict Med. 2020 12; 14(6):518-519. PMID: 32187110.
    Citations:    Fields:    
  2. Becker WC, Krebs EE, Edmond SN, Lin LA, Sullivan MD, Weiss RD, Gordon AJ. A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference. J Gen Intern Med. 2020 12; 35(Suppl 3):978-982. PMID: 33145681.
    Citations:    Fields:    
  3. Taghian NR, McHugh RK, Griffin ML, Chase AR, Greenfield SF, Weiss RD. Associations between Childhood Abuse and Chronic Pain in Adults with Substance Use Disorders. Subst Use Misuse. 2021; 56(1):87-92. PMID: 33131372.
    Citations:    Fields:    
  4. McHugh RK, Trinh CD, Griffin ML, Weiss RD. Validation of the craving scale in a large sample of adults with substance use disorders. Addict Behav. 2021 02; 113:106651. PMID: 33086155.
    Citations:    Fields:    
  5. Lipsitz SR, Fitzmaurice GM, Weiss RD. Using Multiple Imputation with GEE with Non-monotone Missing Longitudinal Binary Outcomes. Psychometrika. 2020 12; 85(4):890-904. PMID: 33006740.
    Citations:    Fields:    
  6. Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D, Weiss RD, Samet JH, Larochelle MR. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis. JAMA Netw Open. 2020 10 01; 3(10):e2016228. PMID: 33052402.
    Citations: 1     Fields:    Translation:Humans
  7. Suzuki J, Weiss RD. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? J Addict Med. 2020 Sep 08. PMID: 32909980.
    Citations:    Fields:    
  8. Weiss RD. Establishing the First Annual Meetings of the American Academy of Addiction Psychiatry. Am J Addict. 2020 09; 29(5):373-374. PMID: 32902043.
    Citations:    Fields:    Translation:Humans
  9. McHugh RK, Geyer RB, Chase AR, Griffin ML, Bogunovic O, Weiss RD. Sex differences in benzodiazepine misuse among adults with substance use disorders. Addict Behav. 2021 01; 112:106608. PMID: 32861991.
    Citations:    Fields:    
  10. Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. J Addict Med. 2020 Jul/Aug; 14(4):282-286. PMID: 31634202.
    Citations: 1     Fields:    
  11. McHugh RK, Votaw VR, Taghian NR, Griffin ML, Weiss RD. Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use. J Subst Abuse Treat. 2020 10; 117:108061. PMID: 32811622.
    Citations: 1     Fields:    
  12. King CD, Hilton BT, Greenfield SF, McHugh RK, Griffin ML, Weiss RD, Ressler KJ. Anxiety sensitivity and grit as mediators between childhood abuse and relapse risk for substance use. Child Abuse Negl. 2020 Sep; 107:104568. PMID: 32559552.
    Citations:    Fields:    
  13. Votaw VR, Witkiewitz K, Vowles KE, Weiss RD, Griffin ML, McHugh RK. Pain interference and catastrophizing are not associated with polysubstance use among treatment-seeking patients with substance use disorders and chronic pain. Am J Drug Alcohol Abuse. 2020 09 02; 46(5):604-612. PMID: 32529847.
    Citations:    Fields:    
  14. Peckham AD, Griffin ML, McHugh RK, Weiss RD. Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder. Drug Alcohol Depend. 2020 Jun 12; 213:108122. PMID: 32563846.
    Citations:    Fields:    
  15. Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, McRae-Clark AL, Montoya I, Peters EN, Ramey T, Turk DC, Vandrey R, Weiss RD, Strain EC. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug Alcohol Depend. 2020 07 01; 212:107993. PMID: 32360455.
    Citations: 1     Fields:    
  16. McHugh RK, Janes AC, Griffin ML, Taghian N, Greenfield SF, Weiss RD. Clinical Correlates of Smoking Status in Men and Women with Opioid Use Disorder. Subst Use Misuse. 2020; 55(7):1054-1058. PMID: 32037945.
    Citations:    Fields:    
  17. Connery HS, Weiss RD. Discontinuing Buprenorphine Treatment of Opioid Use Disorder: What Do We (Not) Know? Am J Psychiatry. 2020 02 01; 177(2):104-106. PMID: 32008394.
    Citations: 1     Fields:    Translation:Humans
  18. Fitzmaurice GM, Lipsitz SR, Weiss RD. Within-treatment frequency of use versus abstinence as a predictor of longitudinal post-treatment follow-up assessments of drug use. Drug Alcohol Depend. 2020 03 01; 208:107857. PMID: 31968301.
    Citations:    Fields:    Translation:Humans
  19. Suzuki J, Robinson D, Mosquera M, Solomon DA, Montgomery MW, Price CD, Johnson JA, Martin B, Liebschutz JW, Schnipper JL, Weiss RD. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. Am J Addict. 2020 03; 29(2):155-159. PMID: 31930608.
    Citations:    Fields:    Translation:Humans
  20. Pedrelli P, Borsari B, Merrill JE, Fisher LB, Nyer M, Shapero BG, Farabaugh A, Hayden ER, Levine MT, Fava M, Weiss RD. Evaluating the combination of a Brief Motivational Intervention plus Cognitive Behavioral Therapy for Depression and heavy episodic drinking in college students. Psychol Addict Behav. 2020 Mar; 34(2):308-319. PMID: 31855009.
    Citations: 1     Fields:    Translation:Humans
  21. Copersino ML, Patel R, Price JS, Visser KF, Vitaliano G, Plitman E, Lukas SE, Weiss RD, Janes AC, Chakravarty MM. Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry. Drug Alcohol Depend. 2020 01 01; 206:107728. PMID: 31740207.
    Citations:    Fields:    Translation:Humans
  22. Kleykamp BA, Weiss RD, Strain EC. Time to Reconsider the Role of Craving in Opioid Use Disorder. JAMA Psychiatry. 2019 11 01; 76(11):1113-1114. PMID: 31339512.
    Citations: 1     Fields:    Translation:Humans
  23. McDermott KA, Griffin ML, McHugh RK, Fitzmaurice GM, Jamison RN, Provost SE, Weiss RD. Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder. Drug Alcohol Depend. 2019 12 01; 205:107675. PMID: 31715440.
    Citations: 2     Fields:    Translation:Humans
  24. Beard C, Peckham AD, Griffin ML, Weiss RD, Taghian N, McHugh RK. Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders. Drug Alcohol Depend. 2019 12 01; 205:107644. PMID: 31698320.
    Citations:    Fields:    Translation:Humans
  25. Kleykamp BA, De Santis M, Dworkin RH, Huhn AS, Kampman KM, Montoya ID, Preston KL, Ramey T, Smith SM, Turk DC, Walsh R, Weiss RD, Strain EC. Craving and opioid use disorder: A scoping review. Drug Alcohol Depend. 2019 12 01; 205:107639. PMID: 31683241.
    Citations:    Fields:    Translation:Humans
  26. Connery HS, Taghian N, Kim J, Griffin M, Rockett IRH, Weiss RD, Kathryn McHugh R. Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder. Drug Alcohol Depend. 2019 12 01; 205:107612. PMID: 31627077.
    Citations: 3     Fields:    Translation:Humans
  27. McHugh RK, Kneeland ET, Edwards RR, Jamison R, Weiss RD. Pain catastrophizing and distress intolerance: prediction of pain and emotional stress reactivity. J Behav Med. 2020 08; 43(4):623-629. PMID: 31376099.
    Citations:    Fields:    Translation:Humans
  28. Kelly JF, Hoffman L, Vilsaint C, Weiss R, Nierenberg A, Hoeppner B. Peer support for mood disorder: Characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization. J Affect Disord. 2019 08 01; 255:127-135. PMID: 31150942.
    Citations:    Fields:    Translation:Humans
  29. Kneeland ET, Griffin ML, Taghian N, Weiss RD, McHugh RK. Associations between pain catastrophizing and clinical characteristics in adults with substance use disorders and co-occurring chronic pain. Am J Drug Alcohol Abuse. 2019; 45(5):488-494. PMID: 31021654.
    Citations: 3     Fields:    Translation:Humans
  30. Carroll KM, Weiss RD. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. Focus (Am Psychiatr Publ). 2019 Apr; 17(2):183-192. PMID: 32021588.
    Citations:    
  31. Weiss RD, Griffin ML, Marcovitz DE, Hilton BT, Fitzmaurice GM, McHugh RK, Carroll KM. Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence. J Clin Psychiatry. 2019 03 26; 80(2). PMID: 30920187.
    Citations: 5     Fields:    Translation:Humans
  32. Beckwith N, McDowell MJ, Reisner SL, Zaslow S, Weiss RD, Mayer KH, Keuroghlian AS. Psychiatric Epidemiology of Transgender and Nonbinary Adult Patients at an Urban Health Center. LGBT Health. 2019 Feb/Mar; 6(2):51-61. PMID: 30707624.
    Citations: 5     Fields:    Translation:Humans
  33. McHugh RK, Weiss RD. Alcohol Use Disorder and Depressive Disorders. Alcohol Res. 2019 10 21; 40(1). PMID: 31649834.
    Citations: 7     Fields:    Translation:Humans
  34. Kiluk BD, Fitzmaurice GM, Strain EC, Weiss RD. Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point. Addiction. 2019 01; 114(1):21-23. PMID: 30474162.
    Citations:    Fields:    Translation:Humans
  35. Connery HS, Weiss RD. Microscopes and Telescopes: the Societal Impact of Substance Use Disorder Treatment. Am J Psychiatry. 2018 10 01; 175(10):925-926. PMID: 30269546.
    Citations:    Fields:    Translation:Humans
  36. Fitzmaurice GM, Lipsitz SR, Weiss RD. Sensitivity analysis for non-monotone missing binary data in longitudinal studies: Application to the NIDA collaborative cocaine treatment study. Stat Methods Med Res. 2019 Oct-Nov; 28(10-11):3057-3073. PMID: 30146938.
    Citations:    Fields:    Translation:Humans
  37. McHugh RK, Geyer R, Karakula S, Griffin ML, Weiss RD. Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use. Am J Addict. 2018 09; 27(6):485-490. PMID: 30028048.
    Citations: 7     Fields:    Translation:Humans
  38. Faberman J, Provost SE, Weiss RD, Greenfield SF. Focus Group Study to Examine Content of Family Meetings in Short-term Substance Use Disorder Treatment. J Soc Work Pract Addict. 2018; 18(3):231-248. PMID: 30505244.
    Citations:    
  39. Kiluk BD, Fitzmaurice GM, Strain EC, Weiss RD. What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning? Addiction. 2019 01; 114(1):9-15. PMID: 29900624.
    Citations: 16     Fields:    Translation:Humans
  40. Welsh JW, Tretyak V, McHugh RK, Weiss RD, Bogunovic O. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. Drug Alcohol Depend. 2018 08 01; 189:96-107. PMID: 29906718.
    Citations:    Fields:    Translation:Humans
  41. Fitzmaurice GM, Lipsitz SR, Weiss RD. Statistical considerations in the choice of endpoint for drug use disorder trials. Drug Alcohol Depend. 2017 12 01; 181:219-222. PMID: 29102827.
    Citations: 5     Fields:    Translation:Humans
  42. Hill KP, Palastro MD, Gruber SA, Fitzmaurice GM, Greenfield SF, Lukas SE, Weiss RD. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study. Am J Addict. 2017 Dec; 26(8):795-801. PMID: 28921814.
    Citations: 5     Fields:    Translation:Humans
  43. Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. JAMA Intern Med. 2017 09 01; 177(9):1265-1272. PMID: 28715535.
    Citations: 24     Fields:    Translation:Humans
  44. Medlock MM, Rosmarin DH, Connery HS, Griffin ML, Weiss RD, Karakula SL, McHugh RK. Religious coping in patients with severe substance use disorders receiving acute inpatient detoxification. Am J Addict. 2017 Oct; 26(7):744-750. PMID: 28836712.
    Citations: 2     Fields:    Translation:Humans
  45. McHugh RK, Votaw VR, Barlow DH, Fitzmaurice GM, Greenfield SF, Weiss RD. Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods. Contemp Clin Trials. 2017 09; 60:105-112. PMID: 28689852.
    Citations: 5     Fields:    Translation:Humans
  46. Greenfield SF, Weiss RD. Addiction-25 Years Later. Harv Rev Psychiatry. 2017 May/Jun; 25(3):97-100. PMID: 28475500.
    Citations:    Fields:    Translation:Humans
  47. Weiss RD, Rao V. The Prescription Opioid Addiction Treatment Study: What have we learned. Drug Alcohol Depend. 2017 Apr 01; 173 Suppl 1:S48-S54. PMID: 28363320.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  48. McHugh RK, Votaw VR, Fulciniti F, Connery HS, Griffin ML, Monti PM, Weiss RD. Perceived barriers to smoking cessation among adults with substance use disorders. J Subst Abuse Treat. 2017 03; 74:48-53. PMID: 28132700.
    Citations: 3     Fields:    Translation:Humans
  49. Carroll KM, Weiss RD. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. Am J Psychiatry. 2017 08 01; 174(8):738-747. PMID: 27978771.
    Citations: 42     Fields:    Translation:Humans
  50. Griffin ML, McDermott KA, McHugh RK, Fitzmaurice GM, Weiss RD. Grit in patients with substance use disorders. Am J Addict. 2016 Dec; 25(8):652-658. PMID: 27759947.
    Citations: 3     Fields:    
  51. Karakula SL, Weiss RD, Griffin ML, Borges AM, Bailey AJ, McHugh RK. Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users. Drug Alcohol Depend. 2016 Dec 01; 169:68-72. PMID: 27776247.
    Citations: 3     Fields:    Translation:Humans
  52. Mackie SE, McHugh RK, McDermott K, Griffin ML, Winkelman JW, Weiss RD. Prevalence of restless legs syndrome during detoxification from alcohol and opioids. J Subst Abuse Treat. 2017 02; 73:35-39. PMID: 28017182.
    Citations: 1     Fields:    Translation:Humans
  53. McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addict Behav. 2017 02; 65:283-288. PMID: 27575980.
    Citations: 14     Fields:    Translation:Humans
  54. Votaw VR, Wittenauer J, Connery HS, Weiss RD, McHugh RK. Perceived risk of heroin use among nonmedical prescription opioid users. Addict Behav. 2017 02; 65:218-223. PMID: 27544695.
    Citations: 7     Fields:    Translation:Humans
  55. Hill KP, Weiss RD. Minimal Physical Health Risk Associated With Long-term Cannabis Use--But Buyer Beware. JAMA. 2016 Jun 07; 315(21):2338-9. PMID: 27272585.
    Citations: 5     Fields:    Translation:HumansAnimals
  56. Griffin ML, McDermott KA, McHugh RK, Fitzmaurice GM, Jamison RN, Weiss RD. Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug Alcohol Depend. 2016 Jun 01; 163:216-21. PMID: 27161860.
    Citations: 7     Fields:    Translation:Humans
  57. McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain. J Pain. 2016 07; 17(7):806-14. PMID: 27058161.
    Citations: 19     Fields:    Translation:Humans
  58. McHugh RK, Fitzmaurice GM, Griffin ML, Anton RF, Weiss RD. Association between a brief alcohol craving measure and drinking in the following week. Addiction. 2016 06; 111(6):1004-10. PMID: 26780476.
    Citations: 10     Fields:    Translation:Humans
  59. Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ. A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. Am J Addict. 2016 Mar; 25(2):94-8. PMID: 26894822.
    Citations: 7     Fields:    Translation:Humans
  60. McHugh RK, Fulciniti F, Mashhoon Y, Weiss RD. Cue-induced craving to paraphernalia and drug images in opioid dependence. Am J Addict. 2016 Mar; 25(2):105-9. PMID: 26848719.
    Citations: 3     Fields:    Translation:Humans
  61. Copersino ML, Price JS, Frost KH, Vitaliano GD, Frederick BD, Lukas SE, Weiss RD, Janes AC. Default Mode Network Functional Reorganization During Early Abstinence in Polysubstance-Using Emerging Adults Treated for Opioid Dependence. J Neuropsychiatry Clin Neurosci. 2016; 28(4):325-327. PMID: 26792100.
    Citations:    Fields:    
  62. Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, Potter J, Ang A, Hser YI, Ling W, Schackman BR. Short term health-related quality of life improvement during opioid agonist treatment. Drug Alcohol Depend. 2015 Dec 01; 157:121-8. PMID: 26511766.
    Citations: 8     Fields:    Translation:Humans
  63. Keuroghlian AS, Reisner SL, White JM, Weiss RD. Substance use and treatment of substance use disorders in a community sample of transgender adults. Drug Alcohol Depend. 2015 Jul 01; 152:139-46. PMID: 25953644.
    Citations: 33     Fields:    Translation:Humans
  64. Griffin ML, Bennett HE, Fitzmaurice GM, Hill KP, Provost SE, Weiss RD. Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study. Am J Addict. 2015 Jun; 24(4):308-14. PMID: 25808055.
    Citations: 11     Fields:    Translation:Humans
  65. Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug Alcohol Depend. 2015 May 01; 150:112-9. PMID: 25818060.
    Citations: 34     Fields:    Translation:Humans
  66. Greenfield SF, Weiss RD. Harvard Review of Psychiatry. Introduction. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):61-2. PMID: 25747919.
    Citations:    Fields:    Translation:Humans
  67. DeVido J, Bogunovic O, Weiss RD. Alcohol use disorders in pregnancy. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):112-21. PMID: 25747924.
    Citations: 10     Fields:    Translation:Humans
  68. Hearon BA, Pierce CL, Björgvinsson T, Fitzmaurice GM, Greenfield SF, Weiss RD, Busch AB. Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen. Am J Drug Alcohol Abuse. 2015 Mar; 41(2):173-6. PMID: 25700005.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  69. McDermott KA, Griffin ML, Connery HS, Hilario EY, Fiellin DA, Fitzmaurice GM, Weiss RD. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry. 2015 Feb; 76(2):189-94. PMID: 25562462.
    Citations: 7     Fields:    Translation:Humans
  70. Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2015 Jan; 24(1):10-4. PMID: 25823630.
    Citations: 7     Fields:    Translation:Humans
  71. Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2014 Nov 06. PMID: 25376754.
    Citations:    
  72. McHugh RK, Fitzmaurice GM, Carroll KM, Griffin ML, Hill KP, Wasan AD, Weiss RD. Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug Alcohol Depend. 2014 Dec 01; 145:121-6. PMID: 25454409.
    Citations: 23     Fields:    Translation:Humans
  73. Northrup TF, Stotts AL, Green C, Potter JS, Marino EN, Walker R, Weiss RD, Trivedi M. Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model. Addict Behav. 2015 Feb; 41:20-8. PMID: 25282598.
    Citations: 17     Fields:    Translation:Humans
  74. Levy S, Weiss R, Sherritt L, Ziemnik R, Spalding A, Van Hook S, Shrier LA. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014 Sep; 168(9):822-8. PMID: 25070067.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
  75. McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23. PMID: 25179587.
    Citations: 20     Fields:    Translation:Humans
  76. McHugh RK, Nielsen S, Weiss RD. Prescription drug abuse: from epidemiology to public policy. J Subst Abuse Treat. 2015 Jan; 48(1):1-7. PMID: 25239857.
    Citations: 20     Fields:    Translation:Humans
  77. Potter JS, Dreifuss JA, Marino EN, Provost SE, Dodd DR, Rice LS, Fitzmaurice GM, Griffin ML, Weiss RD. The multi-site prescription opioid addiction treatment study: 18-month outcomes. J Subst Abuse Treat. 2015 Jan; 48(1):62-9. PMID: 25189089.
    Citations: 11     Fields:    Translation:Humans
  78. Hilario EY, Griffin ML, McHugh RK, McDermott KA, Connery HS, Fitzmaurice GM, Weiss RD. Denial of urinalysis-confirmed opioid use in prescription opioid dependence. J Subst Abuse Treat. 2015 Jan; 48(1):85-90. PMID: 25115135.
    Citations: 7     Fields:    Translation:Humans
  79. Macias Konstantopoulos WL, Dreifuss JA, McDermott KA, Parry BA, Howell ML, Mandler RN, Fitzmaurice GM, Bogenschutz MP, Weiss RD. Identifying patients with problematic drug use in the emergency department: results of a multisite study. Ann Emerg Med. 2014 Nov; 64(5):516-25. PMID: 24999283.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  80. Schuman-Olivier Z, Weiss RD, Hoeppner BB, Borodovsky J, Albanese MJ. Emerging adult age status predicts poor buprenorphine treatment retention. J Subst Abuse Treat. 2014 Sep; 47(3):202-12. PMID: 24953168.
    Citations: 29     Fields:    Translation:HumansPHPublic Health
  81. Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun; 10(3):159-68. PMID: 24944066.
    Citations: 6     Fields:    Translation:Humans
  82. Weiss RD, Griffin ML, Potter JS, Dodd DR, Dreifuss JA, Connery HS, Carroll KM. Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management? Drug Alcohol Depend. 2014 Jul 01; 140:118-22. PMID: 24831754.
    Citations: 8     Fields: